Though some cancer patients lack sufficient enzymes to metabolize capecitabine or 5-FU, many patients are not warned about the risks associated with these treatments.

Here, we show that forcing a metabolic change in embryonic stem cells (ESCs) promotes a developmental identity that better approximates the inner cell mass (ICM) of the early mammalian blastocyst in ...

How do we think, feel, remember, or move? These processes involve synaptic transmission, in which chemical signals are transmitted between nerve cells using molecular containers called vesicles. Now, ...

You take capecitabine and temozolomide as cycles of treatment. This means you take the drugs and then have a rest to allow your body to recover. Each cycle lasts 4 weeks (28 days). You usually have up ...

But what if Parkinson’s could be treated directly at its source by actually restoring the lost neurons? That is exactly what stem cell therapies aim to do. Stem cells have the potential to develop ...

College of Environment and Ecology, Hunan Agricultural University, 1 Nongda Road, Furong District, Changsha 410128, China ...

Paul Stoffels will still exit the company, just sooner than expected. And the Belgian biotech will explore the potential sale of a clutch of cell therapy assets, which Stoffels brought into the ...

Copyright: © 2024 Elsevier Ltd. All rights reserved.

The team at WEHI, including researchers from the Parkinson's Disease Research Center, have identified a small molecule that can selectively block cell death. Published in Science Advances ...

The team has identified a small molecule that can selectively block cell death. Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for ...